In response to last week’s proposed budget cuts to the NIH, a new organization has emerged to help preserve federal funding levels. The Coalition to Save NIH Funding is comprised of stakeholders in healthcare, research, pharmaceutical development, patient advocacy and other nonprofit organizations.
Charles River Laboratories International to pay $1.8M to settle False Claims Act allegations
The Pulse on Site Success by Christophe Berthoux
It has been seven years since the passing of the Biologics Price Competition and Innovation Act, a provision of the Affordable Care Act that created the approval pathway for biosimilars in the U.S. To date, four biosimilar products have been approved by the FDA, compared to 23 products in the European Union where biosimilars have been in play since 2007.